No. 128
:
Mr. Speaker, the following questions will be answered today: Nos. 836, 837 and 842 to 844.
[Text]
Question No. 836—Mr. Martin Shields:
With regard to the federal carbon tax or price on carbon: (a) what is the cumulative amount of carbon tax revenue which has been collected from agricultural producers in the (i) 2019-20, (ii) 2020-21, (iii) 2021-22, fiscal year; (b) what is the projected amount of carbon tax revenue which has been rebated to agricultural producers in the (i) 2019-20, (ii) 2020-21, (iii) 2021-22, fiscal year; (c) what is the cumulative amount of carbon tax revenue projected to be collected from agricultural producers in the (i) 2022-23, (ii) 2023-24, (iii) 2024-25, fiscal year; (d) what is the cumulative amount of carbon tax revenue projected to be rebated to agricultural producers in the (i) 2022-23, (ii) 2023-24, (iii) 2024-25, fiscal year; (e) what are the details of how the amount in (a) was calculated, including a breakdown of how much revenue came from gas, electricity, and other items impacted by the carbon tax; and (f) what is the breakdown of (a) through (d) by province where the federal carbon tax is in effect?
Hon. Chrystia Freeland (Deputy Prime Minister and Minister of Finance, Lib.):
Mr. Speaker, the federal fuel charge is generally not paid directly by consumers of fuel. Rather, the federal fuel charge is generally paid to the Canada Revenue Agency through monthly returns filed by producers or distributors of fuel. These returns only account for aggregate amounts. Typically, once the fuel charge has been paid by a fuel producer or distributor, there is no further reporting of who finally directly bears the cost of the federal fuel charge.
The Greenhouse Gas Pollution Pricing Act, or GGPPA, provides significant up-front relief for farmers from the fuel charge. Notably, the GGPPA provides farmers with relief from the fuel charge for gasoline and light fuel oil (e.g., diesel) used in tractors and other farm machinery. The relief is provided through the use of exemption certificates when certain conditions are met. As the fuel charge is ultimately not paid by the registered distributor upon delivery when an exemption certificate applies, there is no reported amount of this relief.
In addition, recognizing that many farmers use natural gas and propane in their operations, the Government of Canada recently implemented a refundable tax credit to return a portion of fuel charge proceeds directly to farming businesses operating in backstop fuel charge provinces, currently Ontario, Manitoba, Saskatchewan and Alberta, starting in the 2021-22 fuel charge year. The credit aims to help farmers transition to lower-pollution ways of farming, while also maintaining the price signal to reduce emissions.
It is estimated that farmers will receive approximately $100 million in the first year with this amount increasing to approximately $122 million for the 2022-23 fuel charge year. Amounts returned for the 2023-24 fuel charge year and beyond are expected to increase further as the price on pollution continues to rise. Actual amounts returned will depend on the number of farmers claiming the credit and their eligible expenses. As this is the first year of implementation, further information on the actual amount returned through the return of fuel charge to farmers tax credit will not be known until the following fiscal year.
Question No. 837—Ms. Melissa Lantsman:
With regard to the decision by the government to only list one of the five branches of Iran's Islamic Revolutionary Guard Corps (IRGC), namely the Quds Force, as a terrorist entity: (a) why does the government refuse to list the entire IRGC as a terrorist entity; and (b) is there any specific criteria or threshold which the government does not consider to have been met which is preventing the entire IRGC from being listed as a terrorist entity, and, if so, what criteria or threshold has not been met?
Ms. Pam Damoff (Parliamentary Secretary to the Minister of Public Safety, Lib.):
Mr. Speaker, the government has strong measures in place to ensure Iran and the Islamic Revolutionary Guard Corps, or IRGC, are held accountable for their support of terrorism, including some of the toughest and most comprehensive sanctions in the world.
Within the last month an additional 42 individuals and 12 entities were announced to be sanctioned under the special economic measures Iran regulations, or SEMA, in addition to the 202 previously listed Iranian entities and individuals. These measures prohibit dealings related to the listed individuals and entities, some of whom have participated in or enabled gross human rights violations, including against Iranian women, and perpetuated disinformation activities to justify the Iranian regime’s repression and persecution of its citizens. The assets these individuals and entities may hold in Canada will be effectively frozen.
On October 7, 2022, the Prime Minister announced the intention to list the Iranian regime and its top leaders, more than 10,000 officers and senior members, as perpetually inadmissible to Canada for their engagement in terrorism and systemic and gross human rights violations, by pursuing a designation under the Immigration and Refugee Protection Act, or IRPA. This includes heads of state, high ranking officials of the IRGC, intelligence officials, senior public servants, diplomats and members of the judiciary.
In addition to these recent actions, Iran continues to be designated as a state supporter of terrorism under the State Immunity Act.
Moreover, the IRGC’s Quds Force continues to be listed as a terrorist entity under the Criminal Code. In addition to the Quds Force, the government lists a number of terrorist entities under this regime that have benefited from its patronage and that have helped advance Iran’s interests and foreign policy. These include Hezbollah, Hamas, the Palestinian Islamic Jihad, the Taliban Al-Ashtar Brigades, Harakat al-Sabireen and the Fatemiyoun Division. The Criminal Code sets out a terrorist listing regime to help prevent the use of Canada’s financial system to further terrorist activity and to assist in the investigation and prosecution of terrorist offences.
The assessment process for listing a terrorist entity under the Criminal Code is one of continuous analysis to ensure that the process and tools used are rigorous and based on evidence, intelligence as well as domestic and international law.
The government pursues all the tools at its disposal and is working with like-minded countries to continue to keep pressure on Iran to cease its unlawful and terrorist behavior. The government is taking action to ensure that nobody who is responsible for Iran’s egregious actions can operate in Canada. Canadians can be confident in the work performed by our security agencies, which are alert to evolving threats and will not hesitate to take necessary action.
Question No. 842—Mr. Bob Zimmer:
With regard to the government's response to extraterritorial police forces or similar types of foreign entities operating in Canada: (a) what countries is the government aware of that currently have police forces operating in Canada; (b) what is the government's estimate on the number of individuals currently in the country belonging to each force, broken down by country; and (c) has the government taken any specific action to stop Canadian citizens from being harassed, intimidated or otherwise negatively impacted by members of such forces?
Ms. Pam Damoff (Parliamentary Secretary to the Minister of Public Safety, Lib.):
Mr. Speaker, Regarding the Canadian Security Intelligence Service and part (a) of the question, given its mandate and specific operational requirements, CSIS does not generally disclose details related to operational activity. With respect to part (b), given its mandate and specific operational requirements, CSIS does not generally disclose details related to operational activity. With regard to part (c), Canadians should never be subject to harassment or intimidation by foreign actors. As such, CSIS is committed to fulfilling its mandate to investigate threats to the security of Canada and the Canadian population. This includes any foreign influenced activity that is detrimental to the interests of Canada and are clandestine or deceptive, or involve a threat to any person. However, given its mandate and operational requirements, CSIS does not generally disclose details related to specific operational activity.
Regarding the Royal Canadian Mounted Police and part (a) of the question, in order for an international law enforcement agency to operate in Canada they must notify the INTERPOL national central bureau in Ottawa and seek approval under the foreign criminal investigators in Canada, or FCIC, protocol. This protocol sets out Canada’s notification and approval requirements for regulating the entry and monitoring of foreign criminal investigators pursuing foreign criminal investigations in Canada.
The FCIC protocol is aimed at safeguarding Canadian security, sovereignty and public interest, while ensuring adherence by foreign law enforcement and prosecution agencies to applicable Canadian policy and legislation, including the Criminal Code of Canada, the Charter of Rights and Freedoms, and the Privacy Act. As of October 17, 2022, there are currently no international law enforcement agencies operating in Canada under the FCIC protocol.
That said, the RCMP is aware of and is investigating allegations of unauthorized police presence in Canada. Since the investigation is ongoing, there will be no further comment on the matter at this time.
With regard to part (b), as noted in the answer for part (a), there are currently no international law enforcement agencies operating in Canada under the FCIC protocol. The RCMP is aware of and is investigating allegations of unauthorized police presence in Canada. Given the investigation is ongoing, there will be no further comment on the matter at this time.
With regard to part (c), as part of the RCMP’s international policing liaison officer program, the RCMP organizes regular briefings with foreign partners hosted in country to ensure they remain continuously abreast on Canadian laws and legal requirements.
In terms of actions taken, the RCMP works closely with domestic and international partners to counter any hostile activities by foreign states.
Foreign interference, or FI, entails foreign states, targeting Canada’s democratic institutions, economic systems and diaspora communities to advance their political, economic and security interests to the detriment of Canada’s.
The RCMP is mandated by legislation, under section 2 of the Security Offences Act and ministerial direction, to investigate threats to the security of Canada defined in section 2 of the CSIS Act, breaches of security defined in the Security of Offences Act, or SOA, and Security of Information Act, or SOIA, or any other criminal offence or any other federal statute or Criminal Code offence that may have a national security dimension. Further to this, the RCMP acts against FI threats that are criminal or illegal in nature, including acts involving the harassment, intimidation or coercion of individuals or groups within Canada.
The RCMP has several teams, units and efforts in place that contribute to disrupting FI. The RCMP also engages with the Canadian Association of Chiefs of Police to help inform police of jurisdiction of FI threats and to establish mechanisms for reporting FI incidents. Federal policing participates in several interdepartmental efforts to combat FI, including the security and intelligence threats to elections, or SITE, task force, an initiative consisting of the RCMP, Canadian Security Intelligence Service, Communications Security Establishment and Global Affairs Canada, or GAC. FP also participates in the GAC-led rapid response mechanism, a G7 initiative established in 2018 that seeks to strengthen coordination across the G7 in identifying, preventing and responding to threats to G7 democracies.
It is important for all individuals and groups living in Canada, regardless of their nationality, to know that there are support mechanisms in place to assist them when experiencing harassment and intimidation. Anyone who feels threatened online or in person, should report these incidents to their local police. If someone in the public is in immediate danger, they should call 911 or contact their local police. Individuals may also contact the RCMP national security information network by phone at 1-800-420-5805 or by email at RCMP.NSIN-RISN.GRC@rcmp-grc.gc.ca. Service is available in Canada’s both official languages.
Question No. 843—Mr. Stephen Ellis:
With regard to employees at Health Canada, as of September 29, 2022: (a) what is the total number of employees at the director general level or higher; (b) of the employees in (a), how many (i) are a doctor of medicine (MD), (ii) have a doctorate in a medical field, but are not MDs, (iii) have a doctorate in another field, broken down by field; and (c) what are the details of each employee at the director general level or higher that has such a background, including, for each, their (i) title, (ii) relevant degrees?
Mr. Adam van Koeverden (Parliamentary Secretary to the Minister of Health and to the Minister of Sport, Lib.):
Mr. Speaker, with respect to part (a) of the question, the answer is 79. With respect to part (b)(i), the answer is zero employees. Please note that in addition to the 79 executives in part (a), there are six medical doctors at the MD MOF-04 and -05 levels who serve either as senior medical advisers to DG levels or higher; or hold executive positions below the DG level. With respect to part (b)(ii), it is one employee, and for part (b)(iii), it is five employees. With respect to part (c), of the 79 DGs or higher, and the six MD MOF-04s and -05s the breakdown is as follows: six MD-MOFs, one doctorate in a medical field, and five doctorates in other fields. Please note that education is personal information so further details on positions and types of degrees cannot be disclosed.
Question No. 844—Mr. Colin Carrie:
With regard to purchases of COVID-19 vaccine doses by the government: has the government purchased any doses before the doses being approved by Health Canada, and, if so, what are the details of all such purchases, including the (i) manufacturer, (ii) name of the vaccine, (iii) date of purchase, (iv) number of doses purchased, (v) date of the approval by Health Canada?
Mr. Adam van Koeverden (Parliamentary Secretary to the Minister of Health and to the Minister of Sport, Lib.):
Mr. Speaker, Canada built its vaccine portfolio through advance purchase agreements, or APAs, securing future access to COVID-19 vaccines in development at a time when it was not yet known which vaccine candidates would receive Health Canada authorization, and if so, when. This was done in order to ensure that Canada was at the forefront of receiving life-saving vaccines at the height of the COVID-19 pandemic, while providing suppliers the opportunity to accelerate product development and production capacity, and to engage in the regulatory process. Vaccine candidates were selected with guidance from the COVID-19 vaccine task force, experts who helped identify a diverse portfolio of different vaccine types that were most likely to be effective and delivered the fastest.
The first two agreements, with Moderna and Pfizer, were announced in August 2020, followed by similar agreements with Janssen for Johnson & Johnson, Novavax, Sanofi and GlaxoSmithKline, AstraZeneca/Verity Pharmaceuticals and Serum Institute of India, and Medicago. The agreements included firm commitments to purchase doses as well as access to optional doses should they be required.
Companies began submitting data to Health Canada for regulatory review as early as September 2020. The ability to review data from early development while later-stage clinical trials are under way expedites the regulatory review process.
Before filing a submission for a continuing review, sponsors of clinical trials are expected to have gathered a certain level of evidence on the safety, quality and efficacy of their vaccine. Vaccine applications are reviewed through an independent process and products are authorized based on scientific rigour and medical evidence. Products are not made available for use in the Canadian market until they have received regulatory approval.
Vaccine agreements with suppliers are as follows. For AstraZeneca Vaxzevria COVID-19 vaccine, the manufacturer is AstraZeneca Canada Inc. The date the initial agreement was publicly announced was May 17, 2020. The number of doses purchased was 20 million, and the date of initial approval by Health Canada was February 26, 2021.
For Covishield, the manufacturer is Verity Pharmaceuticals Canada Inc./Serum Institute of India, in collaboration with AstraZeneca Canada Inc. The date the initial agreement was publicly announced was February 26, 2021. The number of doses purchased was two million, and the date of initial approval by Health Canada was February 26, 2021. The authorization expired September 16, 2021.
For Moderna Spikevax COVID-19 vaccine, the manufacturer is Moderna. The date the initial agreement was publicly announced was November 16, 2020. The number of doses purchased was 44 million. The initial agreement, after some options exercised, amendment for 2022-24 was up to 25 million in 2022, up to 35 million in 2023 and up to 35 million in 2024. The date of initial approval by Health Canada was December 23, 2020.
For Pfizer-BioNTech Comirnaty COVID-19 vaccine, the manufacturer was BioNTech Manufacturing GmbH. The date the initial agreement was publicly announced was July 20, 2020. The number of doses purchased was 51 million. The initial agreement, after some options exercised, amendment for 2022-24 was up to 65 million for 2022, up to 60 million in 2023 and up to 60 million in 2024. The date of initial approval by Health Canada was December 09, 2020.
For Janssen Jcovden COVID-19 vaccine, the manufacturer was Janssen Inc., or Johnson & Johnson. The date the initial agreement was publicly announced was August 14, 2020. The number of doses purchased was up to 38 million, and the date of initial approval by Health Canada was March 5, 2021.
For Medicago Covifenz COVID-19 vaccine, the manufacturer was Medicago Inc. The date the initial agreement was publicly announced was October 23, 2020. The number of doses purchased was up to 76 million, and the date of initial approval by Health Canada was February 24, 2022.
For Novavax Nuvaxovid COVID-19 vaccine, the manufacturer was Novavax Inc. The date the initial agreement was publicly announced: August 14, 2020. The number of doses purchased was up to 76 million, and the date of initial approval by Health Canada was February 17, 2022.
For the Sanofi vaccine, the manufacturer was Sanofi. The date initial agreement was publicly announced was July 29, 2020. The number of doses purchased was up to 72 million, and it is still under review by Health Canada.
:
Further to that, Mr. Speaker, if a revised response to Question No. 597, originally tabled on September 20, 2022 and the government's responses to Questions Nos. 834, 835 and 838 to 841 could be made orders for returns, these returns would be tabled immediately.
Some hon. members: Agreed.
[Text]
Question No. 597—Mr. Chris Warkentin:
With regard to the ArriveCAN application: (a) how much money did the government spend developing the application; (b) what is the itemized breakdown of all expenditures related to (a); (c) how much has been spent to date maintaining, updating, or promoting the application; (d) how much money did Shared Services Canada spend to initially develop this application; (e) what is the itemized breakdown of all expenditures related to (d); (f) what are the details of all contracts signed by the government related to the application in any way, including, for each (i) the vendor, (ii) the date, (iii) the value, (iv) the start and end dates, if applicable, (v) the description of goods or services provided, (vi) whether the contract was sole-sourced or awarded through a competitive bidding process; and (g) what is the total cumulative cost (i) incurred to date, (ii) budgeted related to the application?
(Return tabled)
Question No. 834—Ms. Rachel Blaney:
With regard to the Guaranteed Income Supplement (GIS), broken down by province or territory, region and year, from 2012 to present: (a) how many Canadians received the GIS; and (b) of those Canadians receiving the GIS, how many (i) lost the benefit because they filed their income taxes late, (ii) are women who are classified as single, widowed, or divorced?
(Return tabled)
Question No. 835—Ms. Bonita Zarrillo:
With regard to measures targeted to persons with disabilities in Canada and contained in Bill C-30, An Act to amend the Income Tax Act (temporary enhancement to the Goods and Services Tax/Harmonized Sales Tax credit) and in Bill C-31, An Act respecting cost of living relief measures related to dental care and rental housing: (a) how many persons with disabilities will receive the one-time housing benefit and the doubling of the GST rebate; (b) how will the government identify persons with disabilities to receive the one-time housing benefit and the GST rebate; and (c) if the Disability Tax Credit is to be used as the only identifier, what steps will the Canada Revenue Agency take to make sure that the one-time housing benefit and the GST rebate are available to as many persons with disabilities as possible?
(Return tabled)
Question No. 838—Mr. John Nater:
With regard to contracts signed or entered into by the government with Russian vendors since January 1, 2022, and broken down by department, agency, Crown corporation, or other government entity: (a) what are the details of each contract signed with vendors based out of Russia or with a mailing address in Russia, including, for each, the (i) date, (ii) value, (iii) vendor, (iv) description or goods or services being provided, including quantity, (v) duration of contract, if applicable, (vi) file number; (b) for each contract in (a), was it sole-sourced or awarded through a competitive bid process; (c) have any of the contracts in (a) been amended or cancelled as a result of the Russian invasion of Ukraine earlier this year, and, if so, which ones and how was the contract changed; and (d) have any other government contracts been amended or cancelled as a result of the Russian invasion of Ukraine earlier this year, and, if so, what are the details, including, for each, the (i) date, (ii) value, (iii) vendor, (iv) description or goods or services being provided, including quantity, (v) duration of contract, if applicable, (vi) file number, (vii) how the contract was changed?
(Return tabled)
Question No. 839—Mr. Mark Strahl:
With regard to any rules, regulations, or policies put in place by the government since February 2020 in response to the COVID-19 pandemic, broken down by department, agency, Crown corporation, or other government entity: what are the details of each such rule, regulation, or policy, including the (i) date put into place, (ii) date rescinded, or date the measure is scheduled to be rescinded, (iii) detailed summary of the measure put into place, (iv) location or locations where the measure was or is in effect?
(Return tabled)
Question No. 840—Mr. Jake Stewart:
With regard to lump sum signing bonuses paid out to government officials, broken down by fiscal year since 2016-17, and by department or agency: (a) what was the total amount paid out in signing bonuses; (b) how many individuals (i) at or above the executive (EX) level (or equivalent), (ii) below the EX level (or equivalent), received signing bonuses; (c) what was the total amount paid out in signing bonuses to officials (i) at or above the EX level (or equivalent), (ii) below the EX level (or equivalent); (d) what is the breakdown of (a) through (c) by individuals who were new to the public service versus individuals who were already in the public service; and (e) which specific jobs in the public service qualify for lump sum signing bonuses?
(Return tabled)
Question No. 841—Mr. Jake Stewart:
With regard to expenditures and other transactions made by the government using the object code 179 (at-risk pay) or any similar code related to risk pay in the 2021-22 fiscal year, broken down by department or agency: (a) what was the total amount paid out in at-risk pay; (b) how many and what percentage of officials (i) at or above the executive (EX) level (or equivalent), (ii) below the EX level (or equivalent), received at-risk pay; (c) what was the total amount paid out in at-risk pay to officials (i) at or above the EX level (or equivalent), (ii) below the EX level (or equivalent); and (d) what is the breakdown of (a) through (c) by pay for work conducted (i) in Canada, (ii) abroad?
(Return tabled)
[English]
:
Finally, Mr. Speaker, I would ask that all remaining questions be allowed to stand.
Some hon. members: Agreed.